Given that elevated NOS2/COX2 tumor expression is a strong predictor of poor survival among ER– patients and patients with TNBC, we postulated that elevated expression of these enzymes might limit clinical outcome in conjunction with radiation treatment. This evidence concerns the gene PTGS2 and neoplasm.